Literature DB >> 9529214

Effects of blood flow and venous network on the survival of the arterialized venous flap.

S H Woo1, S E Kim, T H Lee, J H Jeong, J H Seul.   

Abstract

The purpose of this study was to evaluate further factors that could explain the survival mechanism in the arterialized venous flap. The authors used 16 canines to investigate the survival rate and pattern of the arterialized venous flap and compared the results with those of the conventional saphenous flap. The number and distribution of draining veins in the arterialized venous flap group were varied to observe their impact on the survival rate and pattern. Gross examination of venous network, blood gas, venogram, blood pressure, and histologic study were also carried out. Although there was no significant difference in final survival rate between conventional flap and arterialized venous flap with two efferent veins (p > 0.01), that of the arterialized venous flap increased significantly as the number of draining veins increased. Blood gas analysis showed that more effective oxygen consumption took place when the number of draining veins increased. By measuring the blood flow and volume at 8 hours after the operation with a laser Doppler flowmeter, it was possible to predict the necrosis of the arterialized venous flap. Attachment to a high pressure arterial blood flow system induced smooth muscle proliferation and neogrowth of elastic fibers in the veins. Furthermore, progressive narrowing of the lumen hastened the development of a collateral circulation, demonstrated on a venogram by the tortuous vessels and neovascularization up to the flap margin. To make it possible to predict and achieve complete survival of the arterialized venous flap, the following criteria must be considered: (a) an arterialized venous flap should be designed to contain most of the venous network in the center, (b) the arterial inflow has to be anastomosed to one afferent vein, (c) two or more efferent veins should drain the arterialized venous flap.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9529214     DOI: 10.1097/00006534-199804050-00019

Source DB:  PubMed          Journal:  Plast Reconstr Surg        ISSN: 0032-1052            Impact factor:   4.730


  7 in total

1.  Arterialized Venous Bone Flaps: An Experimental Investigation.

Authors:  Farzad Borumandi; James P Higgins; Heinz Buerger; Anna Vasilyeva; Memmet Emre Benlidayi; Leman Sencar; Alexander Gaggl
Journal:  Sci Rep       Date:  2016-08-25       Impact factor: 4.379

2.  A New Procedure for Wrapped-Negative Pressure Wound Therapy for Congestion After Arterialized Venous Flap Surgery.

Authors:  Yosuke Niimi; Satoko Mori; Masaki Takeuchi
Journal:  Clin Med Insights Case Rep       Date:  2017-12-13

3.  The complicated role of venous drainage on the survival of arterialized venous flaps.

Authors:  Weidong Weng; Feng Zhang; Bin Zhao; Zhipeng Wu; Weiyang Gao; Zhijie Li; Hede Yan
Journal:  Oncotarget       Date:  2017-03-07

4.  Unconventional Perfusion Flaps in the Experimental Setting: A Systematic Review and Meta-Analysis.

Authors:  Diogo Casal; David Tanganho; Teresa Cunha; Eduarda Mota-Silva; Inês Iria; Diogo Pais; Paula Videira; José Videira-Castro; João Goyri-O'Neill
Journal:  Plast Reconstr Surg       Date:  2019-05       Impact factor: 4.730

5.  The arterialised saphenous venous flow-through flap for managing the radial forearm free flap donor site.

Authors:  Kimberley R Hughes; Alisha Fong; Warren M Rozen; James C S Leong
Journal:  Microsurgery       Date:  2022-03-17       Impact factor: 2.080

6.  The effect of hemodynamic remodeling on the survival of arterialized venous flaps.

Authors:  Hede Yan; Jon Kolkin; Bin Zhao; Zhefeng Li; Shichao Jiang; Wei Wang; Zhen Xia; Cunyi Fan
Journal:  PLoS One       Date:  2013-11-12       Impact factor: 3.240

7.  Effects of Venous Superdrainage and Arterial Supercharging on Dorsal Perforator Flap in a Rat Model.

Authors:  Jun Zheng; Shanshan Xi; Maochao Ding; Hong Li; Wei Xu; Maolin Tang; Shixin Chen
Journal:  PLoS One       Date:  2016-08-11       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.